+91 63557 38311

027 174 88499

Dr. Vivek Kothari

Home / Dr. Vivek Kothari

OPD Timing

Monday to Saturday: 7:00 to 9:00 PM

Dr. Vivek Kothari


Urologist, Uro-Oncologist, Andrologist & Kidney Transplant Surgeon

Dr.Vivek Kothari is a Urologist in Ahmedabad, providing comprehensive General and Advanced Urological care.

Dr Kothari is available daily at KESHAVAM HOSPITAL South Bopal Ahmedabad.

Practicing in his own setup KESHAVAM HOSPITAL , located at Saffal Parisar Road , South Bopal , Ahmedabad , Dr Kothari maintains a unique approach to patient care by utilizing the latest and most effective medical treatment combined with his vast experience. Patient’s overall well being is his top most concern.

His personalized approach has helped to solidify a rewarding, lasting relationship between him & his patients, making him a unique Urologist in Ahmedabad.

Dr.Kothari understands the difficulty of obtaining quality medical care that many people face in an increasingly complex & impersonal Health Care System. He understands and respects the privacy of the patient.

He graduated in MBBS from S.S.G Hospital Baroda in the year 2004.

He specialized in M.S. General Surgery from the same institute in the year 2009.

He did his superspeciality, DNB Urology under the auspicious guidance of Dr.Bapat Sir ,one of the pioneer in Urology from the Pune in the year 2015

He worked dedicatedly in URO-ONCOLOGY for 1.5 years , where he dealt with lot of cases of kidney cancers, bladder cancers, prostate cancers etc. He spent 6 months working with Dr.Hemang Baxi Sir (Uro Onco Robotic Surgeon) at HCG Cancer Hospital, Ahmedabad and 1 year as consultant Uro-oncologist at Gujarat Cancer Research Institute (GCRI), one of the best Government Institute for Cancer care in Ahmedabad.

He served for three years as Assisant Professor (Consultant) in INSTITUTE OF KIDNEY DISEASES AND RESEARCH CENTRE,IKDRC,CIVIL HOSPITAL,Ahmedabad ,where he did almost 100 Kidney Transplants which included Donor Laparoscopic Nephrectomy,

He is also trained in Paediatric Urology, Laparoscpic Urology, Reconstructive Urology and all Endourological procedures like kidney stone, ureter stone & bladder stone removal. His special interest is in field of Laproscopy & Reconstructive Urology.

He is also attached to other corporate hospitals of Ahmedabad.

Dr.Kothari is genuinely interested in patient’s wellbeing & believes in the principle of team work .

Put simply, Dr.Kothari is more than a Urologist,he is one of the great human beings with very humble, kind and compassionate approach towards his patients. He is your guiding hand across the vast Urological landscape continually ensuring that the care you receive in the care you deserve.

It is simply not possible to give excellent care to patient in a quick , easy or offhand fashion. Time personally spent with the patient is the most essential ingredient of excellence in clinical practice. There are simply no shortcuts & no substitutions.


Uro oncology is a branch of urology that deals with management of malignancies of the genitor-urinary tract like that of the kidney, ureter, bladder, prostate, penis & testis.

The treatment of urological cancers depends on the stage of the disease at presentation. Surgery still remains as the predominant form of treatment. However the recent advances have resulted in introduction of minimally invasive and less morbid treatment options.


In renal cancers (Fig. 1), nephron sparing surgery is now the norm for small tumors.


Majority of the urinary bladder tumors (Fig. 2) are non invasive and can be managed with endoscopic surgery ie. TURBT. However in cases of advanced malignancy of the kidney or bladder, radical surgery is still required.


• Prostate cancer is the 2 nd most common malignancy in men. This is a disease of old age and 63% of the cases are diagnosed after the age of 65 years. These patients may present with obstructive lower urinary tract symptoms (LUTS) like poor stream of urine, straining at micturition, hematuria etc. As prostate cancer spreads to the bones, some patients may present with backache or bony pains.

• In India, majority of the patients of prostate cancers are still diagnosed at a late stage where curative treatment is not possible. Screening can help in early diagnosis. For screening, digital rectal examination and a blood test (ie. Sr PSA) is required. If diagnosed in early stage, surgery can be curative. Radiation therapy, for early prostate cancer, has also emerged as an optional competitive treatment.

• If the cancer has spread to the bones (metastasis) then curative treatment is not possible but in majority of such patients survival can be increased with proper treatment. Castration (surgical/medical) is the initial treatment in such cases. Eventually all of these patients reach a castrate resistant stage where the cancer again starts spreading. In Castration Resistant Prostate Cancer (CRPC) other systemic treatments (eg Aberaterone/Chemotherapy) are required and help to prolong survival.


These cancers occur in older men and present with a small pustule, papule or growth over the penis. In 80% of the cases the growth is present on the distal aspect of the penis ie on the glans or prepuce. Phimosis and poor hygiene are major risk factors for developing penile cancer. Delay is seeking treatment is common. Surgery, in the form of partial or total Penectomy with or without groin node dissection is the standard treatment option.


Most commonly present as a painless testicular mass. In late cases due to the spread of cancer the patient may present with a mass in the abdomen or in left side of the neck. In one third of the cases these tumors are misdiagnosed as epididymitis or hydrocele. A scrotal ultrasound and blood tests (AFP, LDH, hCG) help in reaching the diagnosis. Removal of the affected testis (orchiectomy) is required for confirmation of the diagnosis. Depending on the stage of the disease additional treatment may be required. Effective combination chemotherapy have brought testicular cancers even when advanced, under the purview of potentially curative tumors.

Today, the treatment for malignancies of the genito-urinary tract is based on the evidence of randomized controlled multicentre trials which have statistical validity. This has enabled the formulation of treatment guidelines so as to give the best survival benifit.